Skip to main content
. Author manuscript; available in PMC: 2016 Dec 1.
Published in final edited form as: Pediatr Blood Cancer. 2016 Aug 30;63(12):2146–2153. doi: 10.1002/pbc.26161

TABLE 2.

Laboratory values for pre-HU, PBest and recent assessment by deviation from PBest

Low deviation from PBest (N = 22)
High deviation from PBest (N = 53)
P value
N Mean SD N Mean SD
Pre HU

 HbF (%) 19 10.7 5.7 41 6.8 4.8 0.009

 Hb (gm/dl) 18 8.0 1.0 39 8.0 1.0 0.92

 MCV (fl)* 19 83.5 6.2 44 83.9 6.7 0.77

 ARC (×109 |−1) 19 266 85 39 352 137 0.02

 WBC (×109 |−1) 18 12.5 2.4 39 15.5 5.5 0.03

 ANC (×109 |−1) 18 5.4 2.2 39 6.5 4.7 0.81

PBest

 HbF (%) 22 21.9 5.1 53 18.5 6.9 0.07

 HbF increase: pre-HU to PBest 20 11.4 5.7 43 11.8 5.8 0.94

 Hb (gm/dl) 22 9.6 1.4 53 9.0 1.2 0.26

 MCV(fl)* 21 99.4 10.3 51 98.9 10.5 0.81

 ARC (×109 |−1) 22 162 96 53 172 86 0.52

 WBC (×109 |−1) 22 7.6 2.4 53 9.5 4.4 0.04

 ANC (×109 |−1) 22 3.7 1.6 52 4.4 3.5 0.72

Recent assessment

 HbF (%) 21 19.1 4.5 51 11.4 5.5 <0.001

 HbF deviation from PBest (%) 21 11.7 5.3 51 40.1 17.5 <0.001

 Hb (gm/dl) 21 9.5 1.2 51 8.6 1.2 0.005

 MCV(fl)* 21 99.6 11.6 51 95.0 12.2 0.12

 ARC (×109 |−1) 22 194 76 51 276 134 0.02

 WBC (×109 |−1) 21 7.7 2.0 51 10.5 3.7 0.002

 ANC (×109 |−1) 21 3.6 1.4 51 6.8 13.4 0.02
*

Excludes three patients with HbS-Beta0 thalassemia.

Bold font for P values: where significant as P < 0.05.